Tokars JI, Alter MJ, Miller E, et al.: National surveillance of dialysis 13. associated disease in the United States: 1994. ASAIO J 1997, 43:108-119.

United States Renal Data System, 97: Treatment modalities for ESRD 14. patients. Am J Kidney Dis 1997, 30:S54-S66.

Cheung AK, Leypoldt JK: The hemodialysis membranes: a historical perspective, current state and future prospect. Sem Nephrol 1997, 15.


Leypoldt JK, Cheung AK, Agodoa LY, et al.: Hemodialyzer mass transfer-area coefficients for urea increase at high dialysate flow rates. 16. Kidney Int 1997, 51:2013-2017.

Collins AJ, Keshaviah P: High-efficiency, high flux therapies in clinical dialysis. In Clinical Dialysis, edn 3. Edited by Nissenson AR. 17.


Collins AJ: High-flux, high-efficiency procedures. In Principles and Practice of Hemodialysis. Edited by Henrich W. Norwalk, CT: 18.

Appleton & Large; 1996:76-88.

von Albertini B, Bosch JP: Short hemodialysis. Am J Nephrol 1991, 19. 11:169-173.

Keshaviah P, Luehmann D, Ilstrup K, Collins A: Technical requirements for rapid high-efficiency therapies. Artificial Organs 1986, 10:189-194. 20. Shinaberger JH, Miller JH, Gardner PW: Short treatment. In Replacement of Renal Function by Dialysis, edn 3. Edited by Maher 21. JF. Norwell, MA: Kluwer Academic Publishers; 1989:360-381. Barth RH: High flux hemodialysis: overcoming the tyranny of time. Contrib Nephrol 1993, 102:73-97. 22.

Van Ypersele, De Strihou C, Jadoul M, et al.: The working party on dialysis amyloidosis: effect of dialysis membrane and patient's age on signs of dialysis-related amyloidosis. Kidney Int 1991, 39:1012-1019. Koda Y, Nishi S, Miyazaki S, et al.: Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients. Kidney Int 1997, 52:1096-1101.

Chandran PKG, Liggett R, Kirkpatrick B: Patient survival on PAN/AN 69 membrane hemodialysis: a ten year analysis. J Am Soc Nephrol 1993, 4:1199-1204.

Hornberger JC, Chernew M, Petersen J, Garber AM: A multivariate analysis of mortality and hospital admissions with high-flux dialysis. J Am Soc Nephrol 1992, 3:1227-1236.

Hakim RM, Held PJ, Stannard DC, et al.: Effect of the dialysis membrane on mortality of chronic hemodialysis patients. Kidney Int 1996, 50:566-570.

Churchill DN: Clinical impact of biocompatible dialysis membranes on patient morbidity and mortality: an appraisal of evidence. Nephrol Dial Trans 1995, 10(suppl):52-56.

Seres DS, Srain GW, Hashim SA, et al.: Improvement of plasma lipoprotein profiles during high flux dialysis. J Am Soc Nephrol 1993, 3:1409-1415.

Mailloux LU: Dialysis modality and patient outcome. UpToDate Med 1995.

Parker TF III, Wingard RL, Husni L, et al.: Effect of the membrane biocompatibility on nutritional parameters in chronic hemodialysis patients. Kidney Int 1996, 49:551-556.

Ikizler TA, Hakim RM: Nutrition in end-stage renal disease. Kidney Int 1996, 50:343-357.

Hakim RM, Wingard RL, Parker RA, et al.: Effects of biocompatibility on hospitalizations and infectious morbidity in chronic hemodialysis patients. J Am Soc Nephrol 1994, 5:450.

Van Stone JC: Hemodialysis apparatus. In Handbook of Dialysis, edn 2. Edited by Daugirdas JT, Ing TS. Boston/New York: Little, Brown & Co.; 1994:31-52.

0 0

Post a comment